DBS for addictions V1

  • Research type

    Research Study

  • Full title

    Deep brain stimulation for disorders of addiction: mechanisms and a pilot blinded randomized cross-over placebo controlled trial

  • IRAS ID

    316169

  • Contact name

    Valerie Voon

  • Contact email

    vv247@cam.ac.uk

  • Sponsor organisation

    Cambridge University Hospital NHS Foundation Trust and the University of Cambridge

  • ISRCTN Number

    ISRCTN12345678

  • Clinicaltrials.gov Identifier

    NCT12345678

  • Duration of Study in the UK

    3 years, 0 months, 0 days

  • Research summary

    Disorders of addiction like alcohol and opioid use disorder are major public health issues with marked morbidity, mortality and financial burden. Many remain refractory to treatment. Addiction disorders are characterized by abnormal brain networks. This study proposes to use a neurosurgical procedure, deep brain stimulation, designed to deliver stimulation to change brain networks, with longstanding established safety and therapeutic efficacy for movement disorders and obsessive-compulsive disorder. Here we propose a deep brain stimulation study in treatment refractory alcohol and opioid use disorder which has shown efficacy in pilot trials.

    This proposal focuses on theoretical mechanisms underlying addictions recording directly from deep brain structures and the ability to modify core addiction processes. We assess the neurophysiology of incentive cues and negative emotionality underlying cue- and stress-induced relapse. We track these process over the course of abstinence and link them with other core addiction cognitive processes including impulse control and behavioural flexibility. We ask how these processes are influenced by key neurochemicals relevant to addictions. Critically, we then ask how stimulation treatment might influence neurophysiology, networks and behaviour with the goal to identify stimulation- responsive specific biomarkers. This leads us towards the development of closed-loop responsive neurostimulation in the treatment of a relapsing remitting illness. We further assess the potential therapeutic efficacy of deep brain stimulation for addiction in a pilot randomized controlled trial.

    Together these studies provide novel direct mechanistic insights of core theoretical mechanisms of addictions in the living human brain with immediate therapeutic impact leading to the emerging potential for precise responsive neuromodulation.

  • REC name

    Yorkshire & The Humber - Sheffield Research Ethics Committee

  • REC reference

    23/YH/0110

  • Date of REC Opinion

    15 Jun 2023

  • REC opinion

    Further Information Favourable Opinion